NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Hainan Poly Pharm. Co. Ltd (SHE: 300630)
300630 Technical Analysis
5
As on 3rd Jan 2025 300630 STOCK Price closed @ 7.72 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 19.61 & Strong Sell for SHORT-TERM with Stoploss of 19.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300630STOCK Price
Open | 6.81 | Change | Price | % |
High | 7.87 | 1 Day | 0.91 | 13.36 |
Low | 6.55 | 1 Week | -0.06 | -0.77 |
Close | 7.72 | 1 Month | -3.11 | -28.72 |
Volume | 69824787 | 1 Year | -12.06 | -60.97 |
52 Week High 31.68 | 52 Week Low 6.55 |
SHE China Most Active Stocks
000564 | 3.18 | -9.92% |
300059 | 22.86 | -4.71% |
002131 | 2.90 | -6.75% |
000882 | 2.52 | 10.04% |
000785 | 4.17 | 10.03% |
000100 | 4.88 | -1.41% |
000725 | 4.20 | -0.94% |
002269 | 2.46 | 9.82% |
002640 | 4.41 | 4.50% |
002607 | 3.11 | -6.89% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300630 Daily Charts |
300630 Intraday Charts |
Whats New @ Bazaartrend |
300630 Free Analysis |
|
300630 Important Levels Intraday
RESISTANCE | 10.26 |
RESISTANCE | 9.45 |
RESISTANCE | 8.94 |
RESISTANCE | 8.44 |
SUPPORT | 7.00 |
SUPPORT | 6.50 |
SUPPORT | 5.99 |
SUPPORT | 5.18 |
300630 Forecast January 2025
4th UP Forecast | 16.55 |
3rd UP Forecast | 13.72 |
2nd UP Forecast | 11.97 |
1st UP Forecast | 10.22 |
1st DOWN Forecast | 5.22 |
2nd DOWN Forecast | 3.47 |
3rd DOWN Forecast | 1.72 |
4th DOWN Forecast | -1.11 |
300630 Weekly Forecast
4th UP Forecast | 8.90 |
3rd UP Forecast | 8.52 |
2nd UP Forecast | 8.29 |
1st UP Forecast | 8.05 |
1st DOWN Forecast | 7.39 |
2nd DOWN Forecast | 7.15 |
3rd DOWN Forecast | 6.92 |
4th DOWN Forecast | 6.54 |
300630 Forecast2025
4th UP Forecast | 57.78 |
3rd UP Forecast | 41.73 |
2nd UP Forecast | 31.8 |
1st UP Forecast | 21.88 |
1st DOWN Forecast | -6.44 |
2nd DOWN Forecast | -16.36 |
3rd DOWN Forecast | -26.29 |
4th DOWN Forecast | -42.34 |
Hainan Poly Pharm. Co. Ltd ( SHE China Symbol : 300630 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300630 Other Details
Segment | EQ | |
Market Capital | 20278194176.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
300630 Address
300630 Latest News
300630 Business Profile
Hainan Poly Pharm. Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs. The company offers formulations in various therapeutic areas, which include anti-allergy, non-steroid anti-inflammatory, antibiotic, and digestive drugs. Its products include desloratadine preparations in anti-allergy drugs, diclofenac preparations in non-steroidal anti-inflammatory drugs, azithromycin for injection and clarithromycin preparations in antibiotic drugs, and trimebutine maleate preparations in digestive drugs. The company was founded in 1992 and is based in Haikou, China. Address: Guilinyang Economic Development Zone, Haikou, China
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service